The economic burden of diseases in the Nordic countries: A systematic review
Scandinavian Journal of Public Health · 2024-03 · 52 (2) · 234-246
DOI: 10.1177/14034948231153025 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Scandinavian Journal of Public Health, online erschienen am 13.02.2023. Verfasst von Stephan Krog Mayntz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, University of Southern Denmark, Denmark. Hauptthemen laut MEDLINE: Cost of Illness, Health Care Costs. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 83 Literaturangaben.
Abstract (Originalsprache)
Background
Economic burden studies can provide insights into the drivers leading to increasing healthcare costs. It can also provide a more holistic view of how diseases impact the welfare of patients and their families. Having concrete estimates of the economic burden across multiple diseases can help policymakers determine which diseases are economically more burdensome. This study aimed to review and summarise comprehensively economic burden studies across multiple diseases in the Nordic countries between 2000 and 2020.
Methods
According to the 2020 PRISMA statement, a systematic literature review was conducted in PubMed, CINAHL, Academic Search Premier and Global Health databases using key terms related to the economic burden of any disease in Denmark, Finland, Greenland, Iceland, Norway and Sweden. Grey literature was also reviewed.
Results
A total of 10,050 potential titles and abstracts were identified and screened, and 254 full-text papers that met the inclusion criteria were evaluated by two independent reviewers. Of these, 119 articles were included in a qualitative synthesis. Twenty-nine had clearly defined comparison groups, thus able to attribute the costs to the disease. Large variations concerning methodology and cost components were noted. Across diseases, the economic burden ranged from EUR 1668 per patient annually for chronic obstructive pulmonary disease to EUR 93,041 for multiple sclerosis. However, estimates varied widely, even within each disease.
Conclusions
Our review highlights the need for more comparable economic burden studies. Future studies should focus on applying robust methodology and homogeneous cost-reporting methods to inform policymakers about which diseases are economically more burdensome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Research, University of Southern Denmark, Denmark.
- The Interdisciplinary Center on Population Dynamics, University of Southern Denmark, Denmark.
- Danish Institute for Advanced Study, University of Southern Denmark, Denmark.
ORCID-Profile: Angela Y Chang
Zitieren
APA
Mayntz, S. K., Peronard, C. R. F., Søgaard, J., & Chang, A. Y. (2024). The economic burden of diseases in the Nordic countries: A systematic review. Scandinavian Journal of Public Health, 52(2), 234-246. https://doi.org/10.1177/14034948231153025
Vancouver
Mayntz SK, Peronard CRF, Søgaard J, Chang AY. The economic burden of diseases in the Nordic countries: A systematic review. Scandinavian Journal of Public Health. 2024;52(2):234-246. doi:10.1177/14034948231153025
BibTeX
@article{Mayntz2024,
author = {Mayntz, Stephan Krog and Peronard, Cecilie Rose Fossar and Søgaard, Jes and Chang, Angela Y},
title = {The economic burden of diseases in the Nordic countries: A systematic review},
journal = {Scandinavian Journal of Public Health},
year = {2024},
volume = {52},
number = {2},
pages = {234--246},
doi = {10.1177/14034948231153025}
}
EUVIMED